Pharmacy World and Science

, Volume 18, Issue 2, pp 63–68 | Cite as

Non-compliance in elderly people: evaluation of risk factors by longitudinal data analysis

  • H. S. Lau
  • K. S. Beuning
  • A. de Boer
  • A. J. Porsius
  • E. Postma-Lim
  • L. Klein-Beemink
Articles

Abstract

Studies on risk factors for drug non-compliance have not taken into account the possibility of correlated outcomes. We therefore conducted a study into risk factors for non-compliance by using analysis techniques that adjust for these correlations (longitudinal data analysis). Data were obtained from interviews and pharmacy records in a cross-sectional survey in Amsterdam. The subjects were 157 elderly people aged 70 years or older. Of these subjects, 37 were residents of a home for the elderly, 40 were community-dwelling elderly who needed to be visited regularly by a district nurse, and 80 were community-dwelling elderly who did not need to be visited by a distric nurse. Most drugs (78%) were used according to the directions; the remainder (22%) were not used as intended. Odds ratios (95% confidence intervals) for non-compliance for moderate and poor/wrong knowledge of the purpose of a drug as compared with good/correct knowledge were 2.8 (1.2–6.7) and 4.2 (1.5–12), respectively. Drug regimens of two times daily and more than two times daily were associated with odds ratios for non-compliance of 4.5 (1.6–12) and 4.2 (1.7–11), respectively, compared to a regimen of once daily. Compliance increased if a drug was prescribed by a specialist instead of a general practitioner [odds ratio 0.1 (0.04–0.4)]. There was no significant relation between compliance and the number of drugs prescribed to a patient, sex, age, living situation, patient group, or perceived effect. This study, which was based on longitudinal data analysis, demonstrates that in elderly people non-compliance with drug therapy is related to the knowledge of purpose of a drug, the complexity of a drug regimen, and the type of prescriber. The positive association between compliance and the number of drugs prescribed found in former studies was not confirmed.

Keywords

Drug utilization Elderly Interview, home Data interpretation, statistical Patient non-compliance Records, pharmacy 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Anonymous. Need we poison the elderly so often? Lancet 1988;2:20–2.Google Scholar
  2. 2.
    Nolan L, O'Malley K. Prescribing for the elderly; part I: sensitivity of the elderly to adverse drug reactions. J Am Geriatr Soc 1988;36:142–9.Google Scholar
  3. 3.
    Col N, Fanale JE, Kronholm P. The role of medication non-compliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990;150(4):841–5.Google Scholar
  4. 4.
    Darnell JC, Murray MD, Martz BL, Weinberger M. Medication use by ambulatory elderly. J Am Geriatr Soc 1986;34:1–4.Google Scholar
  5. 5.
    Bergman U, Wiholm BE. Drug-related problems causing admission to a medical clinic. Eur J Clin Pharmacol 1981;20(3):193–200.Google Scholar
  6. 6.
    Wright EC. Non-compliance — or how many aunts has Matilda? Lancet 1994;342:909–13.Google Scholar
  7. 7.
    Williamson J, Chopin JM. Adverse reactions to prescribed drugs in the elderly: a multicentre investigation. Age Ageing 1980;9:73–80.Google Scholar
  8. 8.
    Prymonpre RE, Mitenko PA, Sitar DS, Oaki FY, Montgomery PR. Drug-associated hospital admissions in older medical patients. J Am Geriatr Soc 1988;36:1092–8.Google Scholar
  9. 9.
    Ostrom JR, Hammarlund ER, Christensen DB, Plein JB, Kethley AJ. Medication usage in an elderly population. Med Care 1985;23:157–64.Google Scholar
  10. 10.
    Hale WE, May FE, Marks RG, Stewart RB. Drug use in an ambulatory elderly population: a five-year update. Ann Pharmacother 1987;21:530–5.Google Scholar
  11. 11.
    Delafuente JC, Meuleman JR, Conlin M, Hoffman NB, Lowenthal DT. Drug use among functionally active, aged, ambulatory people. Ann Pharmacother 1992;26:179–83.Google Scholar
  12. 12.
    Helling DK, Lemke JH, Semla TP, Wallace RB, Lipson DP, Cornoni-Huntley J. Medication use characteristics in the elderly: the IOWA 65+ rural health study. J Am Geriatr Soc 1987;87:35.Google Scholar
  13. 13.
    Klein LE, German PS, Levine DM, Feroli R, Ardery J. Medication problems among outpatients — a study with emphasis on the elderly. Arch Intern Med 1984;144:1185–8.Google Scholar
  14. 14.
    Murray MD, Darnell J, Weinburger M, Martz BL. Factors contributing to medication noncompliance in elderly public housing tenants. Drug Intell Clin Pharm 1986;20:146–52.Google Scholar
  15. 15.
    Boyd JR, Covington TR, Stanaszek WF, Coussons RT. Drug defaulting; part ii: analysis of noncompliance patterns. Am J Hosp Pharm 1974;31:485–91.Google Scholar
  16. 16.
    Herings RMC. PHARMO: a record linkage system for post-marketing surveillance of prescription drugs in the Netherlands [dissertation]. Utrecht: Utrecht University, 1993:18–19.Google Scholar
  17. 17.
    Van den Brandt PA, Petri H, Dorant E, Goldbohm RA, van de Crommert S. Comparison of questionnaire information and pharmacy data on drug use. Pharm Weekbl [Sci] 1991;13(2):91–6.Google Scholar
  18. 18.
    Hershey JC, Morton BG, Braithwaite-Davis J, Reichgott MJ. Patient compliance with antihypertensive medication. Am J Public Health 1980;70:1081–9.Google Scholar
  19. 19.
    Stanton AL. Determinants of adherence to medical regimens by hypertensive patients. J Behav Med 1987;10:377–94.Google Scholar
  20. 20.
    Hulka BS, Cassel JC, Kupper LL, Burdette JA. Communication, compliance, and concordance between physicians and patients with prescribed medications. Am J Public Health 1976;66:847–53.Google Scholar
  21. 21.
    Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121–30.Google Scholar
  22. 22.
    Spriet A, Beiler D, Dechorgnat J, Simon P. Adherence of elderly patients to treatment with pentoxifylline. Clin Pharmacol Ther 1980;27:1–8.Google Scholar
  23. 23.
    Cramer JA, Spilker B, editors. Patient compliance in medical practice and clinical trials. New York: Raven Press, 1991:3–10.Google Scholar
  24. 24.
    Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Quellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989;261:3273–7.Google Scholar
  25. 25.
    Pullar T, Birtwell AJ, Wiles PG, Hay A, Feely MP. Use of a pharmacologic indicator to compare compliance with tablets prescribed to e taken once, twice, or three times daily. Clin Pharmacol Ther 1988;44:540–5.Google Scholar
  26. 26.
    Kelloway JS, Wyatt RA, Adlis SA. Comparison of patients' compliance with prescribed oral and inhaled asthma medications. Arch Intern Med 1994;154(12): 1349–52.Google Scholar
  27. 27.
    Taggart AJ, Johnson GD, McDevitt DG. Does the frequency of daily dosage influence compliance with digoxin therapy? Br J Clin Pharmacol 1981;1:31–4.Google Scholar
  28. 28.
    Gatley MS. To be taken as directed. J R Coll Gen Pract 1968;16:39–44.Google Scholar
  29. 29.
    Larrat EP, Taubman AH, Willey C. Compliance related problems in the ambulatory population.Am Pharm 1990;NS30:18–23.Google Scholar
  30. 30.
    Dixon WM, Stradling P, Wootton DP. Outpatient PAS therapy. Lancet 1957;2:871–2.Google Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • H. S. Lau
    • 1
  • K. S. Beuning
    • 1
  • A. de Boer
    • 1
  • A. J. Porsius
    • 1
  • E. Postma-Lim
    • 2
  • L. Klein-Beemink
    • 2
  1. 1.Department of Pharmacoepidemiology and Pharmacotherapy, Faculty of PharmacyUtrecht UniversityUtrechtthe Netherlands
  2. 2.District Centre for the Elderly ‘De Flesseman’Amsterdamthe Netherlands

Personalised recommendations